Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years — Stella
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
(51 sites) United States
Scottsdale Medical Imaging, LLC, Scottsdale, Arizona Yale University School of Medicine, New Haven, Connecticut University of Chicago Medical Center, Chicago, Illinois Methodist Medical Center of Illinois, Peoria, Illinois Massachussets General Hospital, Boston, Massachusetts Show all 51 locations Key details Phase
Post-approval monitoring
Collaborators
Bayer AG (Sponsor), Bracco (Sponsor)
Enrollment target
~2,076 participants
Primary completion
December 2028
Last updated January 2026